ClinicalTrials.gov
ClinicalTrials.gov Menu

Study on All-Trans Retinoic Acid, Induction and Consolidation Therapy, and Pegfilgrastim After Consolidation Therapy in Younger Patients With Newly Diagnosed Acute Myeloid Leukemia

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00151242
Recruitment Status : Completed
First Posted : September 8, 2005
Last Update Posted : September 20, 2017
Sponsor:
Information provided by (Responsible Party):
Prof. Dr. Richard Schlenk, University of Ulm

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : August 2011
  Actual Study Completion Date : August 2013
Publications of Results:
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):